Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD-35 tablets in mild to moderate Alzheimer's disease
CTR20181184Phase 2Active
- Sponsor
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AD-35 in Alzheimer's disease (AD), sponsored by Zhejiang Hisun Pharmaceutical Co., Ltd.. Started Jul 2018; status: active.
02
Drugs
AD-35
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20181184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181184.